Vanda Pharmaceuticals (VNDA) Operating Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.46% |
| Dec 31, 2025 | -28.99% |
| Sep 30, 2025 | 18.75% |
| Jun 30, 2025 | 6.15% |
| Mar 31, 2025 | -299.14% |
| Dec 31, 2024 | 6.55% |
| Sep 30, 2024 | -8.42% |
| Jun 30, 2024 | -9.86% |
| Mar 31, 2024 | -30.18% |
| Dec 31, 2023 | -18.33% |
| Sep 30, 2023 | -109.10% |
| Jun 30, 2023 | -243.06% |
| Mar 31, 2023 | -69.77% |
| Dec 31, 2022 | 69.63% |
| Sep 30, 2022 | 12.92% |
| Jun 30, 2022 | 145.13% |
| Mar 31, 2022 | -188.80% |
| Dec 31, 2021 | -20.18% |
| Sep 30, 2021 | -12.53% |
| Jun 30, 2021 | 19.61% |
| Mar 31, 2021 | -1.05% |
| Dec 31, 2020 | 34.99% |
| Sep 30, 2020 | -15.58% |
| Jun 30, 2020 | 7,436.80% |
| Mar 31, 2020 | -102.95% |
| Dec 31, 2019 | -60.56% |
| Sep 30, 2019 | 8.73% |
| Jun 30, 2019 | 574.13% |
| Mar 31, 2019 | -122.81% |
| Dec 31, 2018 | 46.80% |
| Sep 30, 2018 | 59.29% |
| Jun 30, 2018 | 60.24% |
| Mar 31, 2018 | 213.58% |
| Dec 31, 2017 | 56.33% |
| Sep 30, 2017 | -155.87% |
| Jun 30, 2017 | 75.66% |
| Mar 31, 2017 | -1,108.87% |
| Dec 31, 2016 | -0.15% |
| Sep 30, 2016 | 86.36% |
| Jun 30, 2016 | 61.61% |
| Mar 31, 2016 | 16.24% |
| Dec 31, 2015 | -56.09% |
| Sep 30, 2015 | -74.81% |
| Jun 30, 2015 | 46.97% |
| Mar 31, 2015 | -114.77% |
| Dec 31, 2014 | 4,913.05% |
| Sep 30, 2014 | 93.30% |
| Jun 30, 2014 | 18.71% |
| Mar 31, 2014 | -241.14% |
| Dec 31, 2013 | -43.45% |
| Sep 30, 2013 | -59.13% |
| Jun 30, 2013 | 25.24% |
| Mar 31, 2013 | 28.98% |
| Dec 31, 2012 | -19.15% |
| Sep 30, 2012 | 33.27% |
| Jun 30, 2012 | 2.79% |
| Mar 31, 2012 | -40.78% |
| Dec 31, 2011 | -79.41% |
| Sep 30, 2011 | -117.65% |
| Jun 30, 2011 | -21,714.29% |
| Mar 31, 2011 | -99.12% |
| Dec 31, 2010 | 6.46% |
| Sep 30, 2010 | -35.78% |